Whenever you are excited about an idea, an innovation or (the possibility of) an invention, the first step to take is talk to one of the IXA business developers. Even if your idea is still premature and very much ‘under construction’. The sooner you let us know, the better – in particular when protection of intellectual property is at stake. We can inform you about the do’s and don’ts with respect to making your research data and results public.
We have specialized business developers for each research field. From engineering, maths and life sciences to the arts, humanities and social sciences*. They will support you in assessing the opportunities and potential pitfalls of your idea and advise you on the steps to be taken. Questions you can expect from our team are:
The best approach to further advance your idea depends largely on the idea itself and its stage of development. IXA assist in various steps:
In due time, we can assist in matchmaking with companies and investors with expertise, resources, and effective business networks. In addition, IXA can assist you with legal and financial matters throughout the entire collaboration process.
Lets us help you to develop your idea and bring it to fruition.
We're here to assist you at every stage of the process
* IXA has compiled valorisation guides especially tuned to researchers in social sciences and humanities (SSH) and life sciences (medical technology). Read more here.
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News